Online Catalogs
TLPSO-0001 - Psoriatic T cell line, cytokine release (anti-CD3/anti-CD28 stimulation)
| Type of assay | Th17 polarity - Cytokines |
| Biological model | T cells derived from psoriatic lesions |
| Species | Human |
| Endpoint | IL-17 release, or other Th17 cytokines |
| Method | ELISA / EIA |
| Stimulating factor / inducer | Anti-CD3 / Anti-CD28 |
| Reference compound | Cyclosporin A |
| Physio-pathology | T lymphocytes: anti-inflammatory effects/immunosuppression, Psoriasis, Psoriasis, T lymphocytes: anti-inflammatory effects/immunosuppression - cell-mediated and humoral immunity modulation |
Related assays
You are viewing records 1-2 out of 2 total records on 1 pages
Reference
Physio-pathology
Type of assay
Biological model
Species
Endpoint
Method
Stimulating factor / inducer
Restore original settings
 |
Reference | Physio-pathology | Type of assay | Biological model | Species | Endpoint | Method | Stimulating factor / inducer | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 CD4+ T cells, cytokine release (anti-CD3/anti-CD28 stimulation)
| CD4TL-0007 | T lymphocytes: anti-inflammatory effects/immunosuppression, Psoriasis, Psoriasis, T lymphocytes: anti-inflammatory effects/immunosuppression - cell-mediated and humoral immunity modulation | Th17 polarity - Cytokines | CD4+ T cells | Human | IL-17 release, or other Th17 cytokines | ELISA / EIA | Anti-CD3 / Anti-CD28 | |||||||||
 T cells, cytokine release (anti-CD3/anti-CD28 stimulation)
| PBMC-0010 | T lymphocytes: anti-inflammatory effects/immunosuppression, Psoriasis, Psoriasis, T lymphocytes: anti-inflammatory effects/immunosuppression - cell-mediated and humoral immunity modulation | Th17 polarity - Cytokines | PBMCs | Human | IL-17 release, or other Th17 cytokines | ELISA / EIA | Anti-CD3 / Anti-CD28 |
BIOalternatives, 1 bis rue des plantes 86160 GENCAY - France
Tel: +33 (0)549.36.11.37
Fax: +33 (0)549.53.10.29
Contact usFax: +33 (0)549.53.10.29
for service and support
prd=216469&join=1